Thymosin alpha 1 alleviates inflammation and prevents infection in patients with severe acute pancreatitis through immune regulation: a systematic review and meta-analysis.

Although patients using Tα1 showed a trend toward lower incidence of IPN compared to those using a placebo during hospitalization (15.7% vs 18.1%) and within 90 days after randomization (22.4% vs 25.6%), there was a lack of statistical difference.

also in 53,322 other papers